Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
The initiative is focused on a problem that continues to plague cancer outcomes in India
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Late-breaking data presented at WCLC highlight significant and sustained improvements in overall survival, including more than doubling five-year survival rates compared to chemotherapy alone
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Subscribe To Our Newsletter & Stay Updated
